Insights

More Articles Back to Article

EU to implement BCS-based biowaiver guideline in July

The International Council for Harmonisation's M9 guideline on biopharmaceutics classification system-based biowaivers will take effect July 30, according to the European Medicines Agency. The 18-page guideline covers various topics, including which drugs are eligible for a BCS-based biowaiver and how drug solubility and permeability can be evaluated. Regulatory Focus (2/11)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!